Institute of Acoustics, Chinese Academy of Sciences (IACAS) and Beijing Yuande Bio-Medical Engineering Company signed an agreement to set up Zhongke Yuande Medical Acoustic Laboratory on Oct.16, 2006.

The ceremony was held in the lecture hall of Yuande Company, which locates in Beijing Yizhuang Economic Development Area. Ju Qi, the associate director of IACAS and Wu Xiaodong, the General Manager of Yuande Company attended the ceremony and signed an agreement.

According to the agreement, Yuande company would provide necessary funds for the newly established laboratory. Furthermore, considering the progress of the research projects, it would make a long-term investment for the laboratory in the next 10 years.  

The company was listed on the Nasdaq Global Select Market on August 10, 2005 and currently trades under the ticker "CMED". It mainly engaged in developing, manufacturing and marketing medical apparatus and bi-medical products. In cooperation with researchers from Peking University, the company developed its leading product ---- the High Intensity Focused Ultrasound (HIFU) tumor therapy system which is used for the treatment of solid cancers and benign tumors. Besides, the Company's research in chemiluminescence technology has made it to be the first China-based company to successfully grasp the core technology, and the first to have a platform to develop and manufacture both equipment and reagents.

The cooperation of our institute with Yuande company was a new exploration to combine the power of the research organization, the company and the market and an important attempt to quicken the transformation of science and technology results. It is firmly believed that this cooperation mode will promote the medical acoustic research in our institute, bring more and more research fruits, serve the market and clients better and better, and finally achieve the mutual benefit for our institute and the company.